• Profile
Close

The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer

Cancer Causes and Control Aug 16, 2018

Miller EA, et al. - Researchers assessed if lower prostate cancer (PCa) rates reported in men with diabetes are attributable to a lower risk of the disease or a bias in detection from prostate-specific antigen (PSA) testing. For this purpose, they used data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening Trial. They found lower rates of PCa among men with diabetes; this finding was limited to low- and intermediate-grade tumors. Following first positive screening test, the likelihood of being biopsied in men with diabetes was less. Significantly more advanced tumors with higher PSA levels were detected in men diagnosed with low/intermediate-grade tumors. Overall, findings highlight a likely contribution of detection bias to the lower rates of low- and intermediate-grade prostate cancers found in diabetics.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay